Skip to main content
. 2021 Jun 30;11:13603. doi: 10.1038/s41598-021-93179-8

Figure 5.

Figure 5

Incident bleeding events in aspirin users. The incidence of major bleedings with primary prevention aspirin use (black lines) or secondary prevention aspirin use (grey lines) for the entire population (Panel A) of, or according to age intervals as either primary prevention (Panel B) use or secondary prevention (panel C) and age-standardised to 2018.